The market size value per capita in Uruguay for hormones in dosage forms, excluding contraceptives and antibiotics, stood at USD 28.7 in 2023. Analyzing the trend from 2013 to 2023, there was a general upturn, with notable year-on-year variations such as the 5.9% increase from 2020 to 2021 followed by a 7.4% decrease from 2021 to 2022. The compound annual growth rate (CAGR) over the last five years was approximately 1.51%, indicating a consistent growth trend overall.
Future trends to watch for include:
- Potential impacts of new health regulations on hormone market dynamics.
- Technological advancements leading to new product developments.
- Shifts in consumer health awareness affecting demand patterns.
